Antigenic Tumor Cell Variants Obtained with Mutagens
- 1 January 1983
- book chapter
- review article
- Published by Elsevier BV in Advances in Cancer Research
- Vol. 39, 121-151
- https://doi.org/10.1016/s0065-230x(08)61034-9
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Immunogenic variants obtained by mutagenesis of mouse lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytesEuropean Journal of Cancer and Clinical Oncology, 1982
- Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumorEuropean Journal of Cancer and Clinical Oncology, 1981
- Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma.The Journal of Experimental Medicine, 1981
- Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivoEuropean Journal of Cancer (1965), 1981
- Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC)European Journal of Cancer (1965), 1979
- Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybridsEuropean Journal of Cancer (1965), 1979
- Karyotypic normalcy and quasi-normalcy of developmentally totipotent mouse teratocarcinoma cellsDevelopmental Biology, 1978
- Recognition and genetic control of helper determinants for cell surface antigen Thy–1Nature, 1978
- IMMUNOTHERAPY OF EXPERIMENTAL CANCER AS A GUIDE TO THE TREATMENT OF HUMAN CANCERAnnals of the New York Academy of Sciences, 1976
- PARASEXUAL APPROACHES TO THE GENETICS OF MANAnnual Review of Genetics, 1975